Grow your business safely with NEOVIX BIOSCIENCES

All the information you need about NEOVIX BIOSCIENCES to develop and secure your business in France

N HOME > CORPORATES > NEOVIX BIOSCIENCES > BALANCE SHEET ( 2021-10-15)

THE LIST OF BALANCE SHEET : NEOVIX BIOSCIENCES

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-09-30 Public 2021-12-31 Complete
2021-10-15 Public 2020-12-31 Complete
2020-08-31 Public 2019-12-31 Complete
2019-07-26 Public 2018-12-31 Complete
2018-10-22 Public 2017-12-31 Complete
NameNEOVIX BIOSCIENCES
Siren494760713
Closing2020-12-31
Registry code 9201
Registration number 55822
Management number2010B02926
Activity code 6420Z
Closing date n-12019-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2021-10-15
Modification01 Annual accounts entered with accounting inconsistencies at document source
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address92350 LE PLESSIS-ROBINSON
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AB Establishment Expenses 852 239.00 277 576.00 574 663.00 852 239.00
AF Concessions, Patents and Similar Rights 116 117.00 2 218.00 113 899.00 116 117.00
AT Other tangible assets 2 313.00 304.00 2 008.00 2 313.00
BJ TOTAL (I) 4 321 790.00 735 239.00 3 586 551.00 4 321 790.00
BX Customers and related accounts 112 792.00 17 142.00 95 650.00 112 792.00
BZ Other receivables 185 600.00 24 000.00 161 600.00 185 600.00
CF Cash and cash equivalents 1 950 590.00 1 950 590.00 1 950 590.00
CJ TOTAL (II) 2 248 981.00 41 142.00 2 207 840.00 2 248 981.00
CO Grand total (0 to V) 6 570 772.00 776 381.00 5 794 391.00 6 570 772.00
CU Other investments 3 191 484.00 310 440.00 2 881 044.00 3 191 484.00
CX Development or Research and Development Expenses 159 637.00 144 701.00 14 937.00 159 637.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 8 482.00 7 286.00 8 482.00
DB Share, merger, contribution premiums, etc. 4 976 859.00 3 709 205.00 4 976 859.00
DD Legal reserve (1) 417.00 417.00 417.00
DH Retained earnings 531 134.00 727 144.00 531 134.00
DI RESULTS FOR THE YEAR (Profit or Loss) -466 152.00 -196 010.00 -466 152.00
DK Regulated provisions 153 566.00 80 346.00 153 566.00
DL TOTAL (I) 5 204 307.00 4 328 388.00 5 204 307.00
DU Loans and Debts from Credit Institutions (3) 447 628.00 91 978.00 447 628.00
DV Miscellaneous Loans and Financial Debts (4) 2 635.00 2 760.00 2 635.00
DX Trade payables and related accounts 42 252.00 84 355.00 42 252.00
DY Tax and social security liabilities 74 569.00 69 327.00 74 569.00
DZ Fixed asset liabilities and related accounts 559 835.00
EA Other liabilities 23 000.00 23 000.00 23 000.00
EC TOTAL (IV) 590 084.00 831 256.00 590 084.00
EE Grand total (I to V) 5 794 391.00 5 159 644.00 5 794 391.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FG Production sold - services 538 162.00 538 162.00 538 162.00
FJ Net sales 538 162.00 538 162.00 538 162.00
FP Reversals of depreciation and provisions, transfer of expenses 5 308.00
FQ Other income 2.00
FR Total operating income (I) 543 471.00
FS Purchases of goods (including customs duties) 235.00
FW Other purchases and external expenses 81 878.00
FX Taxes, duties, and similar payments 2 900.00
FY Salaries and Wages 320 061.00
FZ Social Security Contributions 142 650.00
GA Operating Expenses - Depreciation and Amortization 186 253.00
GC Operating Expenses - Current Assets: Provisions 41 142.00
GE Other Expenses 122.00
GF Total Operating Expenses (II) 775 241.00
GG - OPERATING RESULT (I - II) -231 770.00
GL Other interest and similar income 650.00
GM Reversals of provisions and transfers of expenses 155 220.00
GP Total financial income (V) 155 870.00
GQ Financial allocations to depreciation and provisions 310 440.00
GR Interest and similar expenses 6 592.00
GU Total financial expenses (VI) 317 032.00
GV - FINANCIAL INCOME (V - VI) -161 162.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -392 932.00
4 - Income statement (continued)Amount year NAmount year N-1
HG Exceptional depreciation and provisions 73 220.00 80 346.00 73 220.00
HH Total exceptional expenses (VIII) 73 220.00 80 346.00 73 220.00
HI - EXCEPTIONAL RESULT (VII - VIII) -73 220.00 -80 346.00 -73 220.00
HL TOTAL REVENUE (I + III + V + VII) 699 341.00 286 758.00 699 341.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 1 165 493.00 482 768.00 1 165 493.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -466 152.00 -196 010.00 -466 152.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 238 546.00 186 253.00 238 546.00
PE DEPRECIATION Total including other intangible assets 238 546.00 185 949.00 238 546.00
QU DEPRECIATION Total Tangible Fixed Assets 304.00
7 - Provisions Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
06 aucun libellé 155 220.00 310 440.00 155 220.00 155 220.00
3X Extraordinary depreciation
3Z Total regulated provisions 80 346.00 73 220.00 80 346.00
6T Receivables 3 387.00 42 142.00 3 387.00 3 387.00
7B Total provisions for depreciation 158 607.00 352 582.00 158 607.00 158 607.00
7C Grand total 238 953.00 425 802.00 158 607.00 238 953.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8A Miscellaneous Loans and Financial Debts 2 635.00 2 635.00 2 635.00
8B Suppliers and Related Accounts 42 252.00 42 252.00 42 252.00
8D Social Security and Other Social Organizations 74 569.00 74 569.00 74 569.00
8K Other liabilities (including liabilities related to repo transactions) 23 000.00 23 000.00 23 000.00
VG Loans with a maturity of up to one year at origin 447 628.00 169 753.00 277 875.00 447 628.00
VS Prepaid expenses 298 392.00 298 392.00 298 392.00
VT TOTAL – STATEMENT OF RECEIVABLES 298 392.00 298 392.00 298 392.00
VY TOTAL – STATEMENT OF LIABILITIES 590 084.00 312 209.00 277 875.00 590 084.00

all companies in France

Complete and comprehensive database.